683 related articles for article (PubMed ID: 23137150)
1. Current challenges and controversies in drug-induced liver injury.
Corsini A; Ganey P; Ju C; Kaplowitz N; Pessayre D; Roth R; Watkins PB; Albassam M; Liu B; Stancic S; Suter L; Bortolini M
Drug Saf; 2012 Dec; 35(12):1099-117. PubMed ID: 23137150
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced liver injury and drug development: industry perspective.
Regev A
Semin Liver Dis; 2014 May; 34(2):227-39. PubMed ID: 24879986
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers of idiosyncratic drug-induced liver injury (DILI) - a systematic review.
Atallah E; Freixo C; Alvarez-Alvarez I; Cubero FJ; Gerbes AL; Kullak-Ublick GA; Aithal GP
Expert Opin Drug Metab Toxicol; 2021 Nov; 17(11):1327-1343. PubMed ID: 34727797
[TBL] [Abstract][Full Text] [Related]
4. Idiosyncratic drug-induced liver injury: an update on the 2007 overview.
Hussaini SH; Farrington EA
Expert Opin Drug Saf; 2014 Jan; 13(1):67-81. PubMed ID: 24073714
[TBL] [Abstract][Full Text] [Related]
5. Predicting and preventing acute drug-induced liver injury: what's new in 2010?
Liss G; Rattan S; Lewis JH
Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1047-61. PubMed ID: 20615079
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced liver injury: a safety review.
García-Cortés M; Ortega-Alonso A; Lucena MI; Andrade RJ;
Expert Opin Drug Saf; 2018 Aug; 17(8):795-804. PubMed ID: 30059261
[TBL] [Abstract][Full Text] [Related]
7. Update on Advances in Research on Idiosyncratic Drug-Induced Liver Injury.
Kim SH; Naisbitt DJ
Allergy Asthma Immunol Res; 2016 Jan; 8(1):3-11. PubMed ID: 26540496
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in biomarkers and therapeutic interventions for hepatic drug safety - false dawn or new horizon?
Clarke JI; Dear JW; Antoine DJ
Expert Opin Drug Saf; 2016 May; 15(5):625-34. PubMed ID: 26923482
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced liver injury: Pathogenesis, epidemiology, clinical features, and practical management.
Björnsson HK; Björnsson ES
Eur J Intern Med; 2022 Mar; 97():26-31. PubMed ID: 34772600
[TBL] [Abstract][Full Text] [Related]
10. Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment?
Teschke R; Schulze J; Eickhoff A; Danan G
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398242
[TBL] [Abstract][Full Text] [Related]
11. Models of Idiosyncratic Drug-Induced Liver Injury.
Yokoi T; Oda S
Annu Rev Pharmacol Toxicol; 2021 Jan; 61():247-268. PubMed ID: 32976738
[TBL] [Abstract][Full Text] [Related]
12. Drug-induced liver injury: recent advances in diagnosis and risk assessment.
Kullak-Ublick GA; Andrade RJ; Merz M; End P; Benesic A; Gerbes AL; Aithal GP
Gut; 2017 Jun; 66(6):1154-1164. PubMed ID: 28341748
[TBL] [Abstract][Full Text] [Related]
13. Idiosyncratic drug-induced liver injury: an overview.
Hussaini SH; Farrington EA
Expert Opin Drug Saf; 2007 Nov; 6(6):673-84. PubMed ID: 17967156
[TBL] [Abstract][Full Text] [Related]
14. In-silico approach for drug induced liver injury prediction: Recent advances.
Saini N; Bakshi S; Sharma S
Toxicol Lett; 2018 Oct; 295():288-295. PubMed ID: 29981923
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of idiosyncratic drug-induced liver injury.
Bell LN; Chalasani N
Semin Liver Dis; 2009 Nov; 29(4):337-47. PubMed ID: 19826967
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers of drug-induced liver injury: progress and utility in research, medicine, and regulation.
McGill MR; Jaeschke H
Expert Rev Mol Diagn; 2018 Sep; 18(9):797-807. PubMed ID: 30080986
[TBL] [Abstract][Full Text] [Related]
17. A human liver organoid screening platform for DILI risk prediction.
Zhang CJ; Meyer SR; O'Meara MJ; Huang S; Capeling MM; Ferrer-Torres D; Childs CJ; Spence JR; Fontana RJ; Sexton JZ
J Hepatol; 2023 May; 78(5):998-1006. PubMed ID: 36738840
[TBL] [Abstract][Full Text] [Related]
18. Review of human risk factors for idiosyncratic drug-induced liver injury: latest advances and future goals.
Björnsson HK; Björnsson ES
Expert Opin Drug Metab Toxicol; 2023 Dec; 19(12):969-977. PubMed ID: 37997265
[TBL] [Abstract][Full Text] [Related]
19. Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Liu Z; Shi Q; Ding D; Kelly R; Fang H; Tong W
PLoS Comput Biol; 2011 Dec; 7(12):e1002310. PubMed ID: 22194678
[TBL] [Abstract][Full Text] [Related]
20. Characteristic molecular and proteomic signatures of drug-induced liver injury in a rat model.
Eun JW; Bae HJ; Shen Q; Park SJ; Kim HS; Shin WC; Yang HD; Jin CY; You JS; Kang HJ; Kim H; Ahn YM; Park WS; Lee JY; Nam SW
J Appl Toxicol; 2015 Feb; 35(2):152-64. PubMed ID: 25231249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
